valproate + haloperidol

Valproate + haloperidol is a combination of two pharmaceutical drugs used together for the treatment of acute mania in bipolar I disorder, and has also been studied as adjunct therapy in schizophrenic psychoses. **Valproate** is primarily an anticonvulsant and mood stabilizer that increases central nervous system levels of gamma-aminobutyric acid (GABA), reducing neuronal excitability and stabilizing mood. **Haloperidol** is a typical antipsychotic that antagonizes dopamine D2 receptors, providing antimanic and antipsychotic effects. When used together, the combination can be effective for controlling manic symptoms in bipolar I disorder, though safety concerns (adverse events, extrapyramidal symptoms) require close monitoring. Clinical studies indicate the combination is effective but may lead to increased adverse effects, such as extrapyramidal symptoms and metabolic changes, compared to other antipsychotic combinations[1][2][3].

Brand names

Haldol + valproate sodium

Other names

valproic acid + haloperidol